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Norovirus GII.4 is recognized as a worldwide cause of nonbacterial outbreaks. In
particular, the GII.4 variant occurs every 2e3 years according to antigenic vari-
ation. The aim of our study was to identify GII.4 variants in outbreaks in Korea
during 2004e2012. Partial VP1 sequence of norovirus GII.4-related outbreaks
during 2004e2012 was analyzed. The partial VP1 sequence was detected with
reverse transcription-polymerase chain reaction, seminested polymerase chain
reaction, and nucleotide sequence of 312-314 base pairs for phylogenetic com-
parison. Nine variants emerged in outbreaks, with the Sydney variant showing
predominance recently. This predominance may persist for at least 3 years,
although new variants may appear in Korea.Noroviruses (NoVs) are recognized as a worldwide
cause of epidemic acute gastroenteritis in all age groups as
a result of their low infectious dose and highly aggressive
characteristics [1]. NoVs are divided into five genogroups
(G), and NoV GI (15 genotypes) and GII (21 genotypes)
are known to contain pathogens that infect humans. In
particular, NoV GII.4 is the prominent genotype detected
in cases of human infection, and this genotype produces
variants in epidemic years and shows genetic character-
istics of quasispecies-associated population diversity
[2,3]. Recently, the GII.4 variants have been divided intouted under the terms of th
.org/licenses/by-nc-nd/4.0
ginal author and source are
ase Control and Prevention13 subcluster types. The New-Orleans and Sydney vari-
ants have been reported as relatively new strains,
described in 2010 and 2012 [4e6]. InKorea, NoV surveys
have been performed continuously since 2004 under the
laboratory surveillance system CaliciNet.
In this study, we analyzed the NoV GII.4 sequences
deposited in the CaliciNet database, and described the
predominance and emergence of the GII.4 variant strain
in Korea from 2004 to 2012.
NoV-related outbreaks were reported in 298 cases
between 2004 and 2012 in Korea (data not shown). Stoole Creative Commons Attribution-NonCommercial-No Derivative
) which permits non-commercial use, distribution, and repro-
credited.
. Published by Elsevier Korea LLC. All rights reserved.
Epidemics of norovirus GII.4 variants in outbreak cases 319samples were provided from 17 regional institutes of
health and environment research to analyze the GII.4
variants. The partial capsid sequence was used to
determine the genotype associated with NoV-related
outbreaks. Viral RNA was extracted using an automated
prep kit (GM-AUTOPREP Kit; Greenmate Biotech
Corp., Seoul, Korea), according to the manufacturer’s
instructions. The NoV genome was detected by con-
ducting a one-step reverse transcription-polymerase
chain reaction (RT-PCR; AccuPower RT/PCR PreMix;
Bioneer, Daejeon, Korea) with NoV-specific primers.
Then, seminested PCR (AccuPower PCR PreMix; Bio-
neer) was performed based on the partial 312e314 base
pair sequence of the capsid region. RT-PCR was per-
formed for NV-GIF1, NV-GIR1, NV-GIIF1, and NV-
GIIR1 according to the genogroup references. For
seminested PCR, NV-GIF2 and NV-GIIF2 were added
to the type-specific sense primers in the PCR mixture
[7]. To improve the diagnostic efficiency, we included a
web-based reporting system, K-CaliciNet, starting in
2007 and a one-step real-time PCR starting in 2008 in
the laboratory surveillance system. Nucleotide
sequencing was performed with an automated
sequencing system (ABI3730xl; Applied Biosystems,
Foster, CA, USA), and the results were reported to
CaliciNet. The nucleotide sequences were aligned with
the CLUSTAL W program in MegAlign package
(Windows version 3.12e). In particular, the GII.4 vari-
ants were clustered with the neighbor-joining method.
References for the GII.4 variants were provided by
GenBank [4e6] and subdivided into 13 subcluster types.
NoV-related outbreaks were continuously reported
for 9 years. However, the incidence of NoV peaked in
2008 and 2012. Most of the NoV GI-associated out-
breaks were caused by infections with mixed genotypes
and/or mixed genogroups including GII, whereas the
GII-associated outbreaks tended to be caused by a single
genogroup or genotype. The distribution of GII.4-related
outbreaks was compared with the total NoV-related
outbreaks, based on the phylogenetic partial sequence.
NoV GII.4 was the most prevalent genotype (60.3%) in
NoV-associated outbreaks for each year examined
(Figure 1).
Nine variants were identified from the GII.4 strains
detected in this period, including the Henry, Farm-
ington, Hunter, Sakai, 2006a, 2006b, 2008, New Orleans
(2010), and Sydney (2012) variants (Figure 2A). The
2006b variant was prominent during the years
2006e2008. The 2008 and New Orleans (2010) variants
emerged between the years 2008 and 2011, but were not
prominent, when compared to the 2006b variant. The
Sydney (2012) variant was detected in 2011, and its
prevalence sharply increased in 2012 (Figures 2A and
2B). The 2008 variant showed a biphasic and retro-
gressive prevalence pattern compared with the 2006b
variant. The sequence identity of the 2006b strain
showed high similarity to that of the New Orleans(2010) strain, which was attributed to one branch of the
group (data not shown). The merged prevalence of these
variants was similar to the prevalence pattern of the
2006b variant (Figure 2B).
NoVs are recognized as important pathogens for
gastroenteritis, although their mechanisms of infection
and pathogenesis are poorly understood because of the
absence of a cell culture system or animal model. For this
reason, most research has been performed through mo-
lecular epidemiological studies and has concentrated on
the NoV GII.4 strain, which is the most prevalent geno-
type worldwide. NoV GII.4 is also a prominent strain in
Korea, causing both outbreak and sporadic cases, as
determined by the laboratory surveillance system (data
not shown). The NoV detection rate increased after the
detection method was changed from multiplex real-time
PCR to conventional RT-PCR, to assess the outbreak
response and laboratory surveillance system starting in
2008. Conventional RT-PCR is able to genotype and
sequence directly, but carries a risk of contamination and
takes a long time to perform. Despite this weakness,
conventional RT-PCR is used as an additional analysis
method for sequencing and genotyping.
The partial VP1 sequence of GII.4 was genetically
analyzed for its variation in the nucleotide sequence.
Emergence of the GII.4 variant was reported as a
biennial event. The 2008 and New Orleans (2010) var-
iants were reported as different variants, but they were
remarkably identical compared with the other variants.
The New Orleans (2010) variant closely clustered with
the 2008 variant, but not the Sydney (2012) variant, on a
phylogenetic tree (data not shown). The merged preva-
lence of the 2008 and New Orleans (2010) variants
showed a similar epidemic trend to that of the 2006b
variant in Korea (Figure 2B). Thus, it is reasonable to
assume that the emergence of scientific variants repre-
sents a biennial event, whereas the emergence of an
epidemic variant represents a quadrennial event, on the
premise that the 2008 and New Orleans (2010) variants
originated from one index strain. In this respect, there
may have been three epidemic events of the NoV GII.4
variants in Korea: the 2006b, 2008 and New Orleans
(2010), and Sydney (2012) variants (Figure 2A and 2B).
The first epidemic event occurred due to the 2006b
variant from 2006 to 2009, but was completely termi-
nated in 2013. The second epidemic event was caused
by the 2008 and New Orleans (2010) variants from 2009
to 2011. The third epidemic event was caused by the
Sydney variant in 2012, at the same time as a global
outbreak, and this event may persist for 3 years.
NoV GII.4 variants have caused several pandemics
[8,9]. One variant 95/96 led to a pandemic outbreak
between 1995 and 2001 [9,10], along with two other
variants in 2002 [11,12] and 2004 [13]. These outbreaks
suggest that reinfection with other types arises from
genetic and antigenic diversity and that immunity is not
permanent, as infection due to repeated exposure was
Figure 1. The number of NoV-related outbreaks from 2004 to 2012. Outbreaks associated with NoV were reported through the
public health reporting system at KNIH. The genogroup was determined using a GI/GII-specific RT-PCR method. GI is shown as a
gray bar, GII as a dark gray bar, and mixed infection (GI&GII) as a black bar. Notably, GII.4-related outbreaks are shown as a dark
gray line. G Z genogroup; KNIH Z Korea National Institute of Health; Nov Z norovirus; RT-PCR Z reverse transcription-
polymerase chain reaction.
Figure 2. Distribution of NoV GII.4 variants in Korea from 2004 to 2012. (A) NoV GII.4 variants are shown in a bar graph,
divided according to the total NoV GII.4 variants in Korea. (B) NoV GII.4 variants are drawn as a full line and predicted variants as
a dotted line. The sum of the 2008 and 2010 variants showed a similar epidemic pattern to that of the 2006b variant. The epidemic
pattern of the Sydney variant was assumed based on the 2006b variant and the sum of the 2008 and 2010 variants. GZ genogroup;
Nov Z norovirus.
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Epidemics of norovirus GII.4 variants in outbreak cases 321statistically significant [14,15]. Therefore, a continuous
study of human NoVs is essential in many fields,
including diagnostic methods, epidemiology, and
development of vaccines among others. The sequence
database used in this study is the major tool for epide-
miological research in Korea. However, no conclusions
could be drawn about the partial VP1 sequence in this
study because a complete VP1 sequence or three-
dimensional-prediction model synthesis is not yet
available. However, these data provided significant in-
sights into the distribution of GII.4 variants and the
predicted emerging strains in Korea since 2004. Efforts
are in progress to obtain additional information on
various strains, and we hope to study the complete viral
genome for NoV soon.Conflicts of interest
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